entertainment -WSS

entertainment

author：explore 2025-09-27 19:29:42 - browse：851

medical device iindentifier — Adding identifiers for medical devices like pacemakers to claims forms would help improve device safety. SEBASTIEN BOZON/AFP via Getty Images

This week, an under-the-radar U.S. government advisory group called the National Committee on Vital and Health Statistics (NCVHS) can vastly improve medical device safety.

The NCVHS, which was founded in 1949, is responsible for developing recommendations and common standards for organizing information and data across the U.S. health care system. This charge includes oversight of the claims forms that facilitate all billing and insurance-related activities. Policymakers and others use claims data to track the flow of medical products and services, spending, quality, and outcomes.

One notable absence from claims forms is specific information about medical devices — products ranging from pacemakers to hip implants and ventilators — which account for nearly $200 billion in annual health care spending. This omission is specific to medical devices; claims forms contain National Drug Codes that enable tracking of pharmaceuticals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Medicare will require more price transparency from hospitals

WSS

FDA approves potent Eli Lilly obesity drug, Zepbound

Sweden knocks USA out of World Cup in penalty kicks

Failure, not just success, should guide future doctors

UCSF medical school apologizes for unethical prisoner experiments

Abortion clinic in Cancun will cater to Americans

Excited delirium, Elijah McClain, and emergency physicians

knowledge

entertainment

focus

Walensky prepares to leave CDC — and Congress — behind

FDA approves Recor Medical high blood pressure device

Affirmative action in medical school literally saved lives

MoonLake credibility takes another hit with mid

Drug repurposing or repositioning? The language matters

McConnell is warmly embraced by Kentucky Republicans amid questions about his health

Malaria cases in Florida and Texas: Here’s what you need to know

Failure, not just success, should guide future doctors

Novavax promises a turnaround & Lilly roils the obesity market

Paxlovid rebound happens. Why and to whom are still a mystery

hotspot

With heat waves through August, officials warn of health risks

Sanofi CEO defends move to abandon profit guidance, boost research

Study: New antibiotic targets gonorrhea as well as last existing drug

FDA approves potent Eli Lilly obesity drug, Zepbound

Sage considers ways to reduce costs following FDA rejection

Google's generative AI to analyze medical images — and talk to docs

hotspot

focus

hotspot

focus